2027 Medicare Changes & AEP Guide: What Every Beneficiary Must Know Before Dec 7
Evaluate Your Plan for 2027: Deductible Increases, the $2,400 Drug Out-of-Pocket Cap, Ending Subsidies, Shrinking PDP Options, and Projected IRMAA Surcharges
Schedule a Free AEP Review →Every year between October 15 and December 7, Medicare beneficiaries face a vital opportunity to audit their healthcare coverage during the Annual Enrollment Period (AEP). With major federal shifts taking effect for 2027—ranging from prescription drug out-of-pocket cap adjustments to the conclusion of temporary premium subsidies—leaving your plan on autopilot could result in significant out-of-pocket expense increases.
To help you determine whether you should keep or change your plan for 2027, we’ve partnered with Alfred the Owl to unpack every confirmed Medicare change, how to decode your Annual Notice of Change (ANOC), and how projected IRMAA surcharges impact your retirement budget.
Part 1: The 8 Major Medicare Changes for 2027 Explained
Heading into 2027, statutory revisions, Inflation Reduction Act (IRA) provisions, and CMS regulations bring significant structural shifts across Medicare Part B, Medicare Advantage (Part C), and Medicare Prescription Drug Coverage (Part D).
1. The Out-of-Pocket Prescription Drug Cap Increases to $2,400
The landmark out-of-pocket prescription drug protection established by federal law continues into 2027, but with an indexed threshold adjustment. While the cap was $2,000 in 2025 and $2,100 in 2026, statutory inflation indexing sets the 2027 maximum out-of-pocket threshold at $2,400.
What it means for you: Once your out-of-pocket spending on covered Part D prescriptions reaches $2,400 in 2027, you enter catastrophic coverage and pay $0 for covered Part D drugs for the rest of the calendar year.
2. Maximum Part D Standard Deductible Rises to $700
For plans that feature an annual prescription drug deductible, the maximum allowable deductible increases by $85—rising from $615 in 2026 to $700 in 2027.
What it means for you: Depending on your plan design, you may have to pay up to the first $700 of gross covered prescription costs before your plan’s initial copays or 25% coinsurance kicks in.
3. Conclusion of the Federal Part D Premium Stabilization Subsidy
The temporary federal Part D Premium Stabilization Demonstration—which artificially lowered standalone drug plan premiums in 2025 and 2026 by approximately $15–$16 per month—officially concludes at the end of 2026 as CMS transitions Part D back to standard market operations.
What it means for you: Enrollees in standalone Part D prescription plans (PDPs) may experience larger monthly premium jumps in 2027 compared to recent years. Reviewing your standalone Part D premium on your ANOC is essential.
4. Rapid Consolidation of Standalone Prescription Drug Plans (PDPs)
The total number of standalone Part D drug plans continues to shrink dramatically across the country. Five years ago, beneficiaries had an average of 30 standalone PDP options per region; by 2026, that number dropped to roughly 11, and further consolidation takes effect in 2027.
What it means for you: Your current standalone drug plan may be discontinued, merged with another plan, or restructured with higher premiums. Do not assume your current plan will remain price-competitive.
5. Expanded Federal Price Negotiations Take Effect
Under the Inflation Reduction Act, federal negotiations expand Medicare’s ability to lower costs on select high-cost brand-name drugs, adding 15 newly negotiated medications to the lowered price framework effective January 1, 2027.
6. Streamlined Enrollment Rules & Agent Protections
CMS finalized key regulatory updates in its Contract Year 2027 Final Rule to reduce consumer friction during AEP. Notable updates include eliminating the strict 48-hour Scope of Appointment (SOA) waiting period for one-on-one appointments and allowing educational and marketing events to occur back-to-back.
7. Refined Medicare Advantage Supplemental Benefits (SSBCI)
Medicare Advantage plans continue refining Special Supplemental Benefits for the Chronically Ill (SSBCI). While traditional marijuana remains federally prohibited, CMS clarified guidelines allowing plans to cover non-intoxicating, FDA-recognized hemp products (such as hemp protein powders or GRAS seed oils) under chronic care perks.
8. Projected 2027 IRMAA Surcharges (Based on 2025 Income)
Higher-income beneficiaries face updated Medicare Part B and Part D Income-Related Monthly Adjustment Amount (IRMAA) surcharges. Because of Medicare’s 2-year lookback rule, your 2027 surcharges are determined by your 2025 tax return (MAGI).
| Single Filers (2025 MAGI) | Joint Filers (2025 MAGI) | Est. Monthly Part B Surcharge | Est. Total Part B Premium |
|---|---|---|---|
| $112,000 or less | $224,000 or less | $0.00 | ~$209.50 |
| $112,001 – $141,000 | $224,001 – $282,000 | ~$83.80 | ~$293.30 |
| $141,001 – $176,000 | $282,001 – $352,000 | ~$209.50 | ~$419.00 |
| $176,001 – $211,000 | $352,001 – $422,000 | ~$335.20 | ~$544.70 |
| $211,001 – $499,999 | $422,001 – $749,999 | ~$460.90 | ~$670.40 |
| $500,000+ | $750,000+ | ~$502.80 | ~$712.30 |
- National Base Beneficiary Premium: $41.33 (up from $38.99 in 2026)
- National Average Monthly Bid Amount: $296.05 (up 23.7% from $239.27 in 2026)
- Maximum Deductible: $700
- Out-of-Pocket Catastrophic Cap: $2,400
Part 2: The Fall Calendar, ANOC & Allowed Changes
The 2026 Fall Timeline: Four Dates That Govern Enrollment
Understanding the timing of Medicare releases gives you the exact blueprint for when to review and act:
- Late September 2026: Plans mail the Annual Notice of Change (ANOC) and Evidence of Coverage (EOC) to all enrollees.
- October 14, 2026: Social Security announces the official 2027 Cost-of-Living Adjustment (COLA).
- October 15 – December 7, 2026: The Medicare Annual Enrollment Period (AEP) window. Any plan selection made takes effect January 1, 2027.
- January 1, 2027: Your 2027 plan benefits and coverage go live.
Decoding Your ANOC Letter
Your Annual Notice of Change (ANOC) is a comparative document. Unlike marketing brochures, it shows a direct side-by-side comparison between your current 2026 coverage terms and your upcoming 2027 terms.
- Monthly Plan Premium: Check if your Medicare Advantage or standalone Part D premium is rising due to the end of federal subsidies.
- Formulary & Tier Changes: Verify if any of your medications moved to a higher tier or now require Prior Authorization or Quantity Limits.
- Provider & Pharmacy Networks: Confirm that your primary doctor, preferred specialists, and local pharmacy remain in-network.
- Supplemental Allowances: Review whether OTC stipends, dental maximums, or vision allowances were modified.
What Changes Can You Make During AEP?
During the Annual Enrollment Period (October 15 – December 7), beneficiaries already enrolled in Medicare have broad freedom to adjust their healthcare and prescription drug coverage. All approved modifications take effect on January 1, 2027. Specifically, you are allowed to:
- Switch from Original Medicare to a Medicare Advantage Plan (Part C): Bundle your hospital, medical, and often prescription drug coverage into a private plan.
- Switch from Medicare Advantage back to Original Medicare: Drop your private plan and return directly to Original Medicare Parts A and B.
- Switch from One Medicare Advantage Plan to Another: Move to a different carrier or plan tier in your region if your doctor network or benefits changed.
- Enroll in, Switch, or Drop a Medicare Part D Prescription Drug Plan: Change your standalone drug coverage to match your 2027 medication needs.
Part 3: Decision Guide & Your AEP Review Checklist
How to Decide If You Need to Change Your Medicare Plan for 2027
You should strongly consider switching your plan during AEP if any of the following apply to your situation:
- Your prescription drug costs are increasing: If a key medication moved to a higher tier, lost preferred status, or has a higher copay under your current plan’s 2027 formulary.
- Your doctor or hospital left the network: If your preferred medical providers are no longer in-network for your Medicare Advantage plan.
- Your plan premium spiked: If your standalone Part D or Medicare Advantage monthly premium increased significantly following the end of federal stabilization subsidies.
- Your health needs or travel plans changed: If you were diagnosed with a new condition requiring specialized care or plan to travel frequently outside your plan’s service area.
Your 4-Step AEP Review Checklist
- Open and Read Your ANOC Immediately: Locate the side-by-side comparison table to spot premium and copay changes.
- Run Your Drug List Through Comparison Tools: Input your exact medication names and dosages into Medicare Plan Finder or consult an independent specialist to verify total annual out-of-pocket costs.
- Confirm Provider In-Network Status: Call your physician’s office or check carrier directories to ensure active 2027 network participation.
- Schedule an Independent Review: Consult an independent advisor who can evaluate 30+ carrier offerings to ensure you aren’t overpaying.
“We are rather proud of our independence, if I may say so myself. Policy Engineer evaluates options across 30+ top-rated insurance carriers side-by-side. You never have to navigate complex formulary guides alone—our guidance is entirely education-first and completely zero-cost to you.”
